Arkolith/Insider Trading/MURA/Form 4

Loew Caroline

Chief Executive Officer, DirectorMural Oncology plc (MURA) · full profile →Form 4 · filed Dec 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2024Sell(S)3K$3.40$9K238K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-137877) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML